Maryna Kochuieva
доктор медицинских наук, профессор
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
The objective: to analyze the impact of complex therapy using L-arginine, ubiquinone (coenzyme Q10), L-carnitine, lycopene, plant extracts and folic acid on the functional state of the endothelium, tolerance to physical activity, indicators of oxidative stress, lipid metabolism and clinical status patients with stable angina pectoris of the III functional class (FC) in comorbidity with arterial hypertension (AH) of the II grade, stage 2. Materials and methods. 100 patients with stable angina pectoris III FC and AH II grade, stage 2 aged 55–68 years participated in the study. The patients were divided into two groups: 50 patients of the 1st group received standard therapy – RAAS blocker, amlodipine, bisoprolol, acetylsalicylic acid and atorvastatin; 50 patients of the 2nd group in addition to standard therapy received a multi-component product of complex action, which includes L-arginine, ubiquinone (coenzyme Q10), Lcarnitine, lycopene, a number of plant extracts and folic acid, in a dose of 1 sachet per day. At the beginning and at the end of the study endothelial functions were assessed, daily blood pressure (BP) was monitored, physical exercise testing was performed, the weekly number of angina attacks and nitroglycerin tablet taking were recorded, oxidative status parameters were studied, quality of life was assessed, and the results were statistically processed. Results. The use of complex action preparation, which includes L-arginine, ubiquinone (coenzyme Q10), L-carnitine, lycopene, plant extracts and folic acid, as adjuvant therapy demonstrated a decrease in the level of indicators of lipid peroxidation (LPO) and an increase levels of antioxidant protection parameters. In the patients of the 2nd group a statistically significant positive dynamics of the blood pressure level was found: the median of daily systolic blood pressure (SBP) decreased to 131.78 mm (p<0.01). A significant decrease in median daytime and nighttime SBP and diastolic blood pressure (DBP) was also determined (p<0.01). The use of a multicomponent preparation of complex action led to a significant decreased of total cholesterol (CHL) by 14.5%, TG by 10.37% and low-density lipoprotein cholesterol by 12.5%. There was also an increased level of high-density lipoprotein cholesterol by 6.48% (р<0.05 for all indicators). The patients of the 2nd group demonstrated a significant increase in tolerance to physical excesses: an increase in the double product by 21.4% and the total amount of the done work by 78.4% compared to the initial values (р<0.05 for both indicators). After 2 months of treatment the difference between the groups in terms of the decrease in the weekly number of angina attacks was statistically significant (р<0.05). This positive trend was accompanied by a decrease in the median number of nitroglycerin tablets taken per week in the 2nd group from 5.4 to 3.0 (р<0.05). In the patients of the 2nd group after 2 months of observation a statistically significant improvement in quality of life indicators according to the “Seattle Angina Questionnaire” was determined (р<0.05). Conclusions. Although all study participants received identical standard antihypertensive and lipid-lowering therapy, adjuvant use of a multicomponent complex of L-arginine, ubiquinone (coenzyme Q10), L-carnitine, lycopene, plant extracts, and folic acid for 2 months demonstrated a reduction in the impact of oxidative stress with parallel restoration of antioxidant mechanisms, improvement in vascular reactivity in patients and daily control of blood pressure, contributed to the correction of the lipid profile with increased tolerance to physical exercise and, as a result of the above-mentioned effects, had a significant positive impact on the quality of life of patients.
Year:
2024
Objective. Determination of the effect of antioxidants on clinical and laboratory parameters in alcohol drinkers with infiltrative newly-diagnosed pulmonary tuberculosis (PTB). Materials and Methods. 109 patients with newly-diagnosed PTB were examined. All patients underwent a comprehensive medical examination, immunological blood tests, determination of the parameters of the oxidative stress-antioxidant defense system. Patients were divided into three main groups, depending on the level of alcohol consumption. Patients in each of the three groups were further divided into two subgroups depending on the treatment regimen. Statistical analysis was performed using the STATISTICA program. Results. In patients who received standard therapy, increased alcohol consumption was associated with a decrease in the positive changes of the majority of inflammation and immune status indicators. This trend, in particular, was observed with regard to the progress of the decay cavities closure, persistence of cough complaints, changes in indicators of the immune-inflammatory (CRP, CD8+, CD4/CD8, PAMW, IPC) and oxidative status (SOD, GPX) (p ≤ 0.05). After the antioxidants had been added, the best improvement of immune-inflammatory and oxidative status was observed in group 2 (p ≤ 0.05). Additional antioxidant therapy in patients with newly-diagnosed PTB, regardless of alcohol consumption, contributed to better positive dynamics of cellular immunity, oxidative stress, and endogenous intoxication. Conclusions. The addition of antioxidant drugs to the standard therapy of patients with newly-diagnosed PTB was accompanied by improved clinical and radiological, oxidative and immune-inflammatory parameters. Antioxidant therapy in such patients, regardless of the initial level of alcohol consumption, promoted better positive dynamics of phagocytic and enzymatic activity of neutrophils, oxidative stress, and endogenous intoxication. The best changes in immune-inflammatory and oxidative status among patients taking antioxidants were observed in those who took alcohol at a health-threatening level.
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (3)
Ivan Hrek
Professor Assistant
-
Anton Rohozhyn
-
T.V. Svyatenko
-
Make your next move.
Prepare your application
Review drafts before you send them.